ArticleCell death & disease2020

RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.

Jikui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.